Prospective Multi-Center Study of Short-Term Outcomes After Complex Cholecystectomy
COMPlex Cholecystectomy Trial (COMPaCT): A Prospective Multi-Center Study of Short-Term Outcomes After Complex Cholecystectomy
1 other identifier
observational
186
1 country
4
Brief Summary
The study aims to evaluate the short-term clinical outcomes after complex robotic-assisted and laparoscopic cholecystectomies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2021
Typical duration for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 11, 2021
CompletedFirst Posted
Study publicly available on registry
May 17, 2021
CompletedStudy Start
First participant enrolled
June 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 27, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 27, 2025
CompletedMay 31, 2025
January 1, 2025
3.6 years
May 11, 2021
May 30, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Conversion to open
The rate of conversion of the cholecystectomy to open, defined as robotic-assisted surgery converted to an open approach
Intra-operative
Number of adverse events
Intra-operative or post-operative adverse events related to the cholecystectomy
Intra-operative through the 30 days follow-up period
Re-admissions
Re-admissions to the hospital related to the cholecystectomy through the 30 days follow-up period
After discharge from the hospital post-procedure through the 30 days follow-up period
Re-operations
Re-operations related to the cholecystectomy through 30 days follow-up
After the procedure but prior to discharge, through the 30 day follow-up period
Secondary Outcomes (8)
Operative time
Intra-operative
Use of intra-operative imaging
Intra-operative
Length of hospital stay
From admission to discharge, up to approximately one week
Biliary anatomy identification
Intra-operative
Change in pain score assessed by the PROMIS 3a from baseline to 14 days
14 days
- +3 more secondary outcomes
Study Arms (2)
Laparoscopic cholecystectomy
Subject has a diagnosis of acute cholecystitis and is admitted through the ER for a laparoscopic cholecystectomy.
Robotic-assisted cholecystectomy
Subject has a diagnosis of acute cholecystitis and is admitted through the ER for a robotic-assisted cholecystectomy.
Interventions
With the patient under general anesthesia, several small incisions are made in the abdomen. Ports are placed, the abdomen is insufflated, and laparoscopic instruments as well as a laparoscope are inserted to complete the cholecystectomy according to the surgeon's standard practice.
With the patient under general anesthesia, several small incisions are made in the abdomen. Ports are placed, the abdomen is insufflated, and the da Vinci Robotic Surgical System (Intuitive) is docked to the patient and used to complete the cholecystectomy according to the surgeon's standard of care.
Eligibility Criteria
Subjects who are eligible based on the inclusion/exclusion criteria may participate in the study. Approximately 100 subjects will be enrolled in each cohort (laparoscopic and robotic-assisted). In each cohort, a maximum of 50% of subjects may be enrolled with a Nassar Grade II, and a minimum of 50% of subjects with either Nassar Grade III or IV may be enrolled.
You may qualify if:
- Subject is between 18 and 80 years of age at the time of surgery
- Subject is a candidate for a cholecystectomy
- Subject has a diagnosis of acute cholecystitis and is being admitted through the Emergency Room (ER)
You may not qualify if:
- A single port (single site or single incision procedure) cholecystectomy will be performed
- Subject will undergo a concomitant procedure
- Subject is contraindicated for surgery or a minimally invasive approach
- Subject has a known bleeding or clotting disorder that is not able to be controlled during surgery
- Pregnant or suspect pregnant
- Subject is mentally handicapped or has a psychological disorder or severe systematic illness that would preclude compliance with the study requirements or ability to provide informed consent
- Subject belonging to other vulnerable population, e.g. prisoner or ward of the state
- Subject is unable to comply with the follow-up visit schedule
- Subject is currently participating in another research study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Baptist Health-South Florida
Miami, Florida, 33176, United States
Progressive Surgical Associates, Silver Cross Hospital
New Lenox, Illinois, 60451, United States
Lovelace Medical Group
Albuquerque, New Mexico, 87102, United States
St. David's Healthcare
Austin, Texas, 78701, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 11, 2021
First Posted
May 17, 2021
Study Start
June 5, 2021
Primary Completion
January 27, 2025
Study Completion
January 27, 2025
Last Updated
May 31, 2025
Record last verified: 2025-01